×

Sen. Grassley: Mylan's EpiPen response 'incomplete'

2:08 PM ET Fri, 9 Sept 2016

CNBC's Meg Tirrell reports the latest on the response from EpiPen maker Mylan to Sen. Chuck Grassley's inquiries over the controversial price hike for the drug.